Taxonomic, genetic, chemical and estrogenic characteristics of Epimedium species.

To understand the factors contributing to estrogenic properties of extracts from the genus Epimedium L. (Berberidaceae), we performed taxonomic, genetic and chemical characterization on 37 specimens from 18 species and related these to estrogen receptor (ERalpha and ERbeta) bioactivity, as measured by reporter genes in stable human cells. Boot strap values derived from amplified fragment length polymorphisms indicated that specimens of E. koreanum, E. brevicornum, E. myrianthum, E. leishanense, and E. membranaceum were genetically distinct and this was supported by their very similar ERalpha activities. In contrast, specimens from E. pubescens and E. sagittatum were diverse both genetically, chemically and in terms of ERalpha and ERbeta bioactivities. Strikingly, a genetic cluster comprising six rare Epimedium species exhibited strongest ERalpha and ERbeta activity, and this bioactivity was positively correlated with content of trace flavonoid aglycones (kaempferol, apigenin, quercetin, luteolin and breviflavone B). In contrast, there was no association between estrogenic activity and the major flavonol glycoside constituents (icariin and epimedin A-C). Although they exhibited equally strong ERalpha and ERbeta activity, E. koreanum can be clearly differentiated from E. pubescens and E. brevicornum by genetic distance and its significantly lower content of epimedin C. Our morphologic, genetic, chemical and bioactivity profiling provide the basis for the production of extracts with reproducible estrogenic properties. Such reproducibility will be critical for the standardization of Epimedium-based products.

[1]  K. M. Chen,et al.  Icariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells. , 2005, Die Pharmazie.

[2]  Willem G Schoonen,et al.  Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  J. J. Liu,et al.  Optimization for quantitative determination of four flavonoids in Epimedium by capillary zone electrophoresis coupled with diode array detection using central composite design. , 2006, Journal of chromatography. A.

[4]  Hao Wu,et al.  Chemical and pharmacological investigations of Epimedium species: a survey. , 2003, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[5]  Francisco Gamarro,et al.  Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2. , 2005, Cancer research.

[6]  S. Milligan,et al.  Estrogenic activity of a polyphenolic extract of the leaves of Epimedium brevicornum. , 2005, Fitoterapia.

[7]  Choon Nam Ong,et al.  Herbal and traditional medicine : molecular aspects of health , 2004 .

[8]  D. McDonnell Mining the complexities of the estrogen signaling pathways for novel therapeutics. , 2003, Endocrinology.

[9]  R. Santen,et al.  Recombinant cell ultrasensitive bioassay for measurement of estrogens in postmenopausal women. , 2005, The Journal of clinical endocrinology and metabolism.

[10]  E. Lobenhofer,et al.  Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. F. Stevens,et al.  The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. , 2000, The Journal of clinical endocrinology and metabolism.

[12]  Y. Shoyama,et al.  Genetic characterization of Epimedium species using random amplified polymorphic DNA (RAPD) and PCR-restriction fragment length polymorphism (RFLP) diagnosis. , 1996, Biological and Pharmaceutical Bulletin.

[13]  B. Efron,et al.  Bootstrap confidence levels for phylogenetic trees. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Chiu,et al.  Effect of Epimedium brevicornum Maxim extract on elicitation of penile erection in the rat. , 2006, Urology.

[15]  P. Shaw,et al.  A phylogenetic analysis of Epimedium (Berberidaceae) based on nuclear ribosomal DNA sequences. , 2005, Molecular phylogenetics and evolution.

[16]  M. Butler,et al.  New estrogenic prenylflavone from Epimedium brevicornum inhibits the growth of breast cancer cells. , 2005, Planta medica.

[17]  P. Xiao,et al.  [Comment on main species of herba epimedii]. , 2003, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[18]  K. Fu,et al.  Studies on contributing factors in temporomandibular disorders. , 1999, The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association.

[19]  Margaret Warner,et al.  Reflections on the Discovery and Significance of Estrogen Receptor (cid:1) , 2005 .

[20]  H. Sirén,et al.  Characterization of flavonoids in extracts from four species of Epimedium by micellar electrokinetic capillary chromatography with diode-array detection. , 1997, Journal of chromatographic science.

[21]  H. Cidade,et al.  Effects of natural prenylated flavones in the phenotypical ER (+) MCF-7 and ER (-) MDA-MB-231 human breast cancer cells. , 2006, Toxicology letters.

[22]  P. Leung,et al.  Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. , 2006, Bone.

[23]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[24]  Y. Li,et al.  Osteoblastic proliferative activity of Epimedium brevicornum Maxim. , 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[25]  P. Shen,et al.  Dimeric progestins from rhizomes of Ligusticum chuanxiong. , 2006, Phytochemistry.